Fetal anemia
- Fetal blood group screening: an audit at Guy’s and St. Thomas’ Hospital, London
- Hemolytic disease of the fetus and newborn: safety, efficacy, and outcomes
- Nipocalimab in pregnancies at risk for severe memolytic disease of the fetus and newborn
- Pregnancies at risk of developing hemolytic disease of the fetus and newborn
- Rhesus mediated hemolytic disease of the fetus and newborn
- Safety and efficacy of Nipocalimab in early-onset severe hemolytic disease of the fetus and newborn (HDFN)
- The clinical characteristics of severe early-onset hemolitic disease of fetus and newborn
- The economic burden of haemolytic disease of the fetus and newborn: a systematic literature review
- The effect of intrauterine transfusions for hemolytic disease of the fetus and newborn